Preclinical study of safety of Dendropanax morbifera Leveille leaf extract: General and genetic toxicology
Graphical abstract
Introduction
Dendropanax morbifera Leveille (DM) is a subtropical broad-leaved evergreen tree belonging to the family Araliaceae. It is known as Hwangchil in Korea, and is an endemic species found in the southwestern region of South Korea, mainly in the Jeju Island (Han et al., 1998). In traditional herbal medicine in Korea, DM is believed to improve blood circulation in Donguibogam (written in the 17th century, Korean) (Choi et al., 2015). Several studies have extensively demonstrated the potential therapeutic benefits of DM such as anti-cancer, anti-thrombotic, anti-diabetic, anti-oxidant, and anti-inflammatory activities (Moon, 2011; Yu et al., 2012a; Hyun et al., 2013; Lee et al., 2013; Kim et al., 2014, 2015; Akram et al., 2016). DM extract has also been reported to display antibiotic activity against Staphylococcus aureus (Lee et al., 1998). Another study performed by the Korean Ministry of Science and Technology (Im et al., 1996) investigated the antibacterial and antifungal effects of the DM extracts.
In recent years, traditional herbal products have gained popularity worldwide because of easy access and convenience (Jiang, 2005; Liu et al., 2008). In particular, they are effective therapeutic targets for research free from adverse side effects (Markman, 2002; Shin et al., 2013). In fact, several lines of evidence suggest the absence of adverse reactions of herbal medicines when administered orally (Ito et al., 2014; Lee et al., 2015a; Yun et al., 2015a). However, the genotoxic or systemic toxicity potentials associated with hepatic/renal dysfunction of a few natural products have been established by our group (Che et al., 2014, 2015; Yun et al., 2015b, 2015c). These studies emphasized the importance of comprehensive safety assessment even for beneficial herbal medicines available on the traditional market. Nonetheless, along with prejudice against the safety of herbal medicine, no safety data regarding potential hazard involved in the DM extract has been assessed according to the test guidelines published by the Organization for Economic Cooperation and Development (OECD). The present studies represent a comprehensive investigation into the subchronic oral toxicity and the clastogenicity profile of the extract derived from the leaves of DM.
Section snippets
Test substance and animals
The leaves of wild DM were collected from Jangheung in Korea in October 2011 and authenticated by Dr. Kim in the field of herbal medicine at the Jeollanamdo Institute of Natural Resources Research (Jangheung, Korea). Voucher specimen (JINR2003) has been deposited at the Jeollanamdo Institute of Natural Resources Research in Korea. Extracts were obtained from the leaves of DM using 20 vol of distilled water (DW) at 100 °C for 4 h. The extracted solution was filtered, concentrated using an
14-Day repeat-dose oral toxicity study
Several phenolic compounds, including rutin and quercetin, have been identified as the major active components of DM extract (Hyun et al., 2015). The amounts of rutin (10.52 mg/g) and quercetin (2.99 mg/g) were estimated in the DM extract used in the present study (data not shown).
No dose-related animal deaths following the administration of DM extract were observed until the scheduled termination during the experimental phase of the 14-day repeat-dose oral toxicity study for the selection of
Discussion
In traditional systems of medicine, various parts (stems, roots, leaves, and seeds) of DM have been used as a form of alternative medicine for several conditions including headache, infectious diseases, skin diseases, and dysmenorrhea (Bae, 2000). Similarly, several attempts were made to exploit the DM-derived substances for their hepatoprotective (Bae et al., 2015), anti-oxidant (Kim et al., 2015), anticomplement (Park et al., 2004; Chung et al., 2011), anti-diabetic (Moon, 2011),
Conclusion
The results demonstrated that the DM extract did not exert any clastogenicity based on the in vitro chromosome aberration assay and in vivo micronucleus assay. More importantly, a 13-week repeated oral administration of the DM extract had no dose-related adverse effects in rats. Under our experimental conditions, the no-observed-adverse-effect-level of the DM extract was >2000 mg/kg/day in both male and female rats and no apparent target organ damage was identified when administered
Conflicts of interest
The authors declare no conflict of interests.
Author contributions
J.W.Y. contributed to the analyzing the data and wrote the manuscript. S.H.K., Y.S.K., J.R.Y., E.Y.C., J.H.Y., and E.K. extracted extracts and performed the biological experiments. H.C.K. participated in the design of the study and provided technical advices. J.J.J. conducted pathological analysis. J.S.P. contributed to the drafting the manuscript. J.H.C. and B.C.K. participated in the design of the study, in discussions and reviewed the manuscript. All authors read and approved the final
Acknowledgements
This work was supported by the Ministry of Knowledge Economy for the Regional Innovation System program in 2011 (No. B0012328, 00000-63206-A000900032) and the Catholic University of Korea, Research Fund, 2018.
References (60)
- et al.
Toxicologic assessment of Paecilomyces tenuipes in rats: renal toxicity and mutagenic potential
Regul. Toxicol. Pharmacol.
(2014) - et al.
Genotoxicity and subchronic toxicity of Sophorae radix in rats: hepatotoxic and genotoxic potential
Regul. Toxicol. Pharmacol.
(2015) - et al.
Assessment of cisplatin-induced kidney injury using an integrated rodent platform
Toxicol. Appl. Pharmacol.
(2013) - et al.
Anti-thrombotic effect of rutin isolated from Dendropanax morbifera Leveille
J. Biosci. Bioeng.
(2015) - et al.
Chemical composition and larvicidal effects of essential oil of Dendropanax morbifera against Aedes aegypti L
Biochem. Syst. Ecol.
(2009) - et al.
Measurement of micronuclei in human lymphocytes
Mutat. Res.
(1985) - et al.
- et al.
Evaluation of anti-oxidant and anti-cancer properties of Dendropanax morbifera Léveille
Food Chem.
(2013) - et al.
Anti-inflammatory activity and phenolic composition of Dendropanax morbifera leaf extracts
Ind. Crops Prod.
(2015) - et al.
Toxicological assessment of enzyme-treated asparagus extract in rat acute and subchronic oral toxicity studies and genotoxicity tests
Regul. Toxicol. Pharmacol.
(2014)
Therapeutic wisdom in traditional Chinese medicine: a perspective from modern science
Trends Pharmacol. Sci.
Two new antifungal compounds from Dendropanax trifidus
Tetrahedron Lett.
Acute and subchronic (28 days) oral toxicity studies of Codonopsis lanceolate extract in SpragueeDawley rats
Regul. Toxicol. Pharmacol.
Acute and chronic toxicity of the aqueous extract of Artemisia afra in rodents
J. Ethnopharmacol.
Isolation and anticomplement activity of compounds from Dendropanax morbifera
J. Ethnopharmacol.
Tetradecanol reduces EL-4 T cell growth by the down regulation of NF-κB mediated IL-2 secretion
Eur. J. Pharmacol.
Clinical chemistry and haematology historical data in control Sprague-Dawley rats from pre-clinical toxicity studies
Exp. Toxicol. Pathol.
Single and 90-day repeated oral dose toxicity studies of fermented Rhus verniciflua stem bark extract in Sprague–Dawley rats
Food Chem. Toxicol.
Safety evaluation of Angelica gigas: genotoxicity and 13-weeks oral subchronic toxicity in rats
Regul. Toxicol. Pharmacol.
Evaluation of subchronic (13 week) toxicity and genotoxicity potential of vinegar-processed Genkwa Flos
Regul. Toxicol. Pharmacol.
Pre-clinical in vitro and in vivo safety evaluation of Cimicifuga heracleifolia
Regul. Toxicol. Pharmacol.
Potent anti-inflammatory and analgesic actions of the chloroform extract of Dendropanax morbifera mediated by the Nrf2/HO-1 pathway
Biol. Pharm. Bull.
Detection of genotoxicity and mutagenicity of chlorthiophos using micronucleus, chromosome aberration, sister chromatid exchange, and Ames tests
Environ. Toxicol.
Hepatoprotective effects of aqueous extracts from leaves of Dendropanax morbifera Leveille against alcohol-induced hepatotoxicity in rats and in vitro anti-oxidant effects
Food Sci. Biotechnol.
The Medicinal Plants of Korea
In vitro evaluation of the antiplasmodial activity of Dendropanax morbifera against chloroquine-sensitive strains of Plasmodium falciparum
Phytother Res.
Antiatherogenic activity of Dendropanax morbifera essential oil in rats
Pharmazie
Anticomplement activity of polyacetylenes from leaves of Dendropanax morbifera Leveille
Phytother Res.
Phylogenetic relationships of the Dendropanax morbifera and D-trifidus based on PCR-RAPD
Kor. J. Genet.
Multienzyme-modified biosensing surface for the electrochemical analysis of aspartate transaminase and alanine transaminase in human plasma
Anal. Bioanal. Chem.
Cited by (9)
Extracts from Dendropanax morbifera leaves ameliorates cerebral ischemia-induced hippocampal damage by reducing oxidative damage in gerbil
2024, Journal of Stroke and Cerebrovascular DiseasesNeuroprotective effects of Dendropanax morbifera leaves on glutamate-induced oxidative cell death in HT22 mouse hippocampal neuronal cells
2020, Journal of EthnopharmacologyCitation Excerpt :Various pharmacological activities have also been reported at the extract levels including protective effects on hippocampus and kidney function (Jung et al., 2018a; Kim et al., 2014, 2015a, 2015b, 2016; Seo et al., 2016) and anti-inflammatory effects (Akram et al., 2016; Choo et al., 2019; Shim et al., 2016). DM was demonstrated to be safe in a subchronic toxicity study using Sprague-Dawley rats (Yun et al., 2019). In particular, the pharmacological activities of DM listed above are highly relevant to most traditional therapeutic applications of DM.
IMMUNIES, a unique polyherbal extract, exhibits antiproliferative activity and improves tumor-bearing canine patients: a pilot study
2023, Journal of Applied Biological Chemistry